Sugi Predict

Sugi Predict / Compounds / SCHEMBL4187310

SCHEMBL4187310

SCHEMBL4187310

Cc1cc(SC(C)(C)C(=O)O)c(C)cc1OCCCc1nc(-c2ccc(C(F)(F)F)cc2)cs1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARD Q03181 13/20 0.51
▸ ALDH1A1 P00352 2/20 0.47
▸ HDAC3 O15379 2/20 0.47
▸ HDAC4 P56524 2/20 0.47
▸ HDAC1 Q13547 2/20 0.47
▸ HDAC7 Q8WUI4 2/20 0.47
▸ HDAC2 Q92769 2/20 0.47
▸ HDAC10 Q969S8 2/20 0.47
▸ HDAC11 Q96DB2 2/20 0.47
▸ HDAC8 Q9BY41 2/20 0.47
▸ HDAC6 Q9UBN7 2/20 0.47
▸ HDAC9 Q9UKV0 2/20 0.47
▸ HDAC5 Q9UQL6 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ SLC22A12 Q96S37 2/20 0.42
▸ PPARA Q07869 9/20 0.41
▸ PPARG P37231 3/20 0.41
▸ ALOX5 P09917 1/20 0.39
▸ PSEN1 P49768 1/20 0.39
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4194429 0.86 PPARD (0.54) PPARDALDH1A1HDAC3HDAC4HDAC1
SCHEMBL2904298 0.85 PPARD (0.44) PPARDALDH1A1L3MBTL1SLC22A12PPARA
SCHEMBL4187458 0.85 PPARD (0.69) PPARDALDH1A1HDAC3HDAC4HDAC1
SCHEMBL4182282 0.84 PPARD (0.52) PPARDALDH1A1HDAC3HDAC4HDAC1
SCHEMBL4189710 0.81 PPARD (0.62) PPARDALDH1A1HDAC3HDAC4HDAC1
SCHEMBL4189800 0.81 PPARD (0.52) PPARDALDH1A1HDAC3HDAC4HDAC1
SCHEMBL4193737 0.80 PPARD (0.63) PPARDALDH1A1HDAC3HDAC4HDAC1
SCHEMBL4191088 0.79 HDAC3 (0.52) PPARDALDH1A1HDAC3HDAC4HDAC1
SCHEMBL4184384 0.79 PPARD (0.63) PPARDALDH1A1HDAC3HDAC4HDAC1
SCHEMBL13774940 0.78 PPARD (0.65) PPARDALDH1A1HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192203-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2009-07-30 — — US claimed
EP-1945620-A2 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2008-07-23 — — EP claimed
WO-2007056366-A2 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-05-18 — — WO claimed
US-20090192203-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2009-07-30 — — US disclosed
US-20090192203-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2009-07-30 — — US disclosed
EP-1945620-A2 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2008-07-23 — — EP disclosed
WO-2007056366-A2 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-05-18 — — WO disclosed
WO-2007056366-A2 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-05-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192203-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS PPARG, PPARA, PPARD PPARD 3/4885ALDH1A1 1696/4885HDAC3 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.